Task: Answer the multiple-choice question.
Question: Which drug exhibits a -11.021\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CN1CCc2c(sc3c2c(=O)n(-c2ccccc2)c2n[nH]c(=S)n32)C1
b: CC1CCN(S(=O)(=O)Cc2ccccc2Cl)CC1
Answer: a. CN1CCc2c(sc3c2c(=O)n(-c2ccccc2)c2n[nH]c(=S)n32)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCc2c(sc3c2c(=O)n(-c2ccccc2)c2n[nH]c(=S)n32)C1
CN1CCc2c(sc3c2c(=O)n(-c2ccccc2)c2n[nH]c(=S)n32)C1
13-methyl-7-phenyl-3-sulfanylidene-16-thia-2,4,5,7,13-pentazatetracyclo[7.7.0.02,6.010,15]hexadeca-1(9),5,10(15)-trien-8-one